Auga Group AB (VSE:AUG1L)

Sage Therapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Aug 5, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	18	72	89	113	101	83
Market Cap Growth	-23.44%	-19.61%	-21.10%	12.16%	21.98%	-9.00%
Enterprise Value	142	189	200	210	193	169
Last Close Price	0.08	0.31	0.39	0.50	0.44	0.36
PE Ratio	-	-	-	-	56.98	-
Forward PE	-	62.00	13.51	39.60	15.42	-
PS Ratio	0.24	0.93	1.23	1.58	1.22	1.16
PB Ratio	0.33	1.16	1.15	1.43	1.09	0.92
P/TBV Ratio	0.37	1.28	1.24	1.51	1.14	0.92
P/FCF Ratio	-	-	-	100.67	14.99	38.08
P/OCF Ratio	-	-	129.32	13.91	7.55	15.29
EV/Sales Ratio	1.90	2.44	2.74	2.93	2.32	2.37
EV/EBITDA Ratio	27.25	-	19.74	514.42	12.49	16.58
EV/EBIT Ratio	-	-	58.08	-	23.66	58.41
EV/FCF Ratio	-28.12	-	-	187.02	28.62	77.69
Debt / Equity Ratio	2.26	2.13	1.60	1.39	1.02	1.04
Debt / EBITDA Ratio	23.88	64.39	6.82	15.96	4.41	5.99
Debt / FCF Ratio	-	-	-	97.77	14.03	43.24
Asset Turnover	0.33	0.34	0.33	0.34	0.40	0.38
Inventory Turnover	1.30	1.44	1.17	1.43	1.40	1.35
Quick Ratio	0.13	0.13	0.16	0.20	0.33	0.25
Current Ratio	0.80	0.65	0.97	1.27	1.58	1.12
Return on Equity (ROE)	-38.64%	-37.73%	-7.95%	-17.97%	1.96%	-3.54%
Return on Assets (ROA)	-2.82%	-3.55%	0.97%	-2.17%	2.42%	0.95%
Return on Capital (ROIC)	-3.49%	-4.14%	1.10%	-2.46%	2.74%	1.09%
Return on Capital Employed (ROCE)	-	-	2.10%	-	4.70%	1.90%
Earnings Yield	-93.22%	-25.63%	-6.07%	-13.62%	1.75%	-3.90%
FCF Yield	-27.65%	-19.19%	-7.29%	0.99%	6.67%	2.63%
Buyback Yield / Dilution	-	-0.94%	-0.53%	-	-	-12.77%

Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.